Keiko Matsuura Selected Research

DNA (Deoxyribonucleic Acid)

2/2014

The Vav3 oncogene enhances the malignant potential of prostate cancer cells under chronic hypoxia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Keiko Matsuura Research Topics

Disease

9	Neoplasms (Cancer) 01/2017 - 07/2006
7	Carcinoma (Carcinomatosis) 01/2016 - 07/2006
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 02/2007
3	Stomach Neoplasms (Stomach Cancer) 12/2016 - 04/2007
2	Neoplasm Metastasis (Metastasis) 02/2017 - 01/2015
2	Prostatic Neoplasms (Prostate Cancer) 02/2014 - 04/2013
2	Hypoxia (Hypoxemia) 02/2014 - 04/2013
2	Contact Dermatitis (Eczema, Contact) 01/2004 - 01/2002
1	Carcinogenesis 01/2020
1	Esophageal Squamous Cell Carcinoma 02/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016
1	B-Cell Lymphoma (Lymphoma, B Cell) 04/2013
1	Aneuploidy (Aneuploid) 06/2011
1	Adenoma (Adenomas) 05/2010
1	Adenocarcinoma 03/2008
1	Leukemia 01/2008
1	Peptic Ulcer (Peptic Ulcers) 04/2007
1	Gastritis 04/2007
1	Muscular Dystrophies (Muscular Dystrophy) 03/2007
1	Lupus Nephritis 03/2007
1	Proteinuria 03/2007
1	Muscular Diseases (Myopathy) 03/2007
1	renal Oncocytoma 02/2007
1	Uterine Cervical Dysplasia 07/2006
1	Granuloma 01/2004
1	Hypersensitivity (Allergy) 01/2004

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 05/2016 - 02/2007
4	Biological ProductsIBA 01/2020 - 06/2011
3	MicroRNAs (MicroRNA)IBA 01/2020 - 03/2010
3	Small Interfering RNA (siRNA)IBA 02/2014 - 06/2011
2	Biomarkers (Surrogate Marker)IBA 02/2017 - 01/2015
2	AndrogensIBA 02/2014 - 04/2013
2	AntigensIBA 04/2008 - 04/2007
2	Cytotoxins (Cytolysins)IBA 04/2008 - 04/2007
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 02/2017
1	Phosphotransferases (Kinase)IBA 12/2016
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2016
1	tyrosine receptor (receptor, tyrosine)IBA 12/2016
1	Ribosomal Protein S6IBA 12/2016
1	Dual Specificity Phosphatase 1IBA 01/2016
1	RNA (Ribonucleic Acid)IBA 02/2014
1	DNA (Deoxyribonucleic Acid)IBA 02/2014
1	Complementary DNA (cDNA)IBA 02/2014
1	Messenger RNA (mRNA)IBA 02/2014
1	Keratin-7 (Cytokeratin 7)IBA 01/2014
1	Keratins (Keratin)IBA 01/2014
1	Capsules (Microcapsules)IBA 01/2014
1	atelocollagenIBA 04/2013
1	Androgen Receptors (Androgen Receptor)IBA 04/2013
1	Caspase 3 (Caspase-3)IBA 04/2013
1	Caspase 9IBA 04/2013
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 04/2013
1	Docetaxel (Taxotere)FDA Link 04/2013
1	Polytetrafluoroethylene (Teflon)FDA Link 01/2013
1	Cathepsin KIBA 01/2013
1	OligonucleotidesIBA 05/2010
1	CaspasesIBA 03/2010
1	ParaffinIBA 01/2010
1	ErbB Receptors (EGF Receptor)IBA 03/2008
1	Gefitinib (Iressa)FDA Link 03/2008
1	AntibodiesIBA 03/2008
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2008
1	AnkyrinsIBA 03/2007
1	Protein Kinases (Protein Kinase)IBA 07/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2004
1	AcidsIBA 01/2004
1	DinitrofluorobenzeneIBA 01/2004
1	OxazoloneIBA 01/2002

Therapy/Procedure

2	Molecular Targeted Therapy 01/2017 - 12/2016
1	Immunotherapy 01/2017
1	Castration 04/2013
1	Therapeutics 04/2013